Smart stenting for heart artery branch blockages
Part of Heart & circulation clinical trials.
This trial tests a new way to treat complex blockages in heart arteries where a side branch is also narrowed. It uses a drug-coated balloon to open the side branch, aiming to improve blood flow and reduce the need for repeat procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older.
- You have a heart condition (acute or chronic coronary syndrome) and need a stent procedure.
- You have a new, complex blockage in a heart artery that involves a side branch that is at least 10mm long and significantly narrowed.
- Your heart's pumping function must be relatively preserved (ejection fraction above 30%).
- You must be able to take blood thinners like aspirin and clopidogrel.
- You should not have a life-threatening illness that limits survival to less than 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial compares two ways to open a specific type of heart blockage that involves both a main artery and a side branch. It tests whether using a drug-coated balloon (“hybrid strategy”) works as well as using a planned two-stent approach (“stepwise provisional strategy”).
This trial compares two ways to treat a narrowed heart artery at a split (bifurcation). It tests whether a simple approach (one stent) is as good as also opening the side branch with another stent, which may help reduce the need for extra procedures.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
This study looks at a new way to place stents in blocked heart arteries that are at a branching point. It aims to improve blood flow and reduce the risk of the blockage coming back, compared to standard methods.
This trial tests using a drug-coated balloon to open a single large heart artery blockage, with special imaging to guide the procedure. It may help avoid a permanent stent.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.